Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Emmi I. Joensuu"'
Autor:
Juha Ranti, Katariina Perkonoja, Tommi Kauko, Heidi Loponen, Emmi I. Joensuu, Tiina M. Järvinen
Publikováno v:
eJHaem, Vol 3, Iss 1, Pp 291-300 (2022)
Abstract Objectives We conducted this retrospective study to characterize the change in chronic lymphocytic leukemia (CLL) treatment patterns between 2005 and 2019, to understand the treatment sequencing across the course of the disease, and to inves
Externí odkaz:
https://doaj.org/article/38a69ec56cf740aba60959a897469a9a
Autor:
Päivi Peltomäki, Sakari Knuutila, Salla Ruosaari, Miina Ollikainen, Wael M. Abdel-Rahman, Emmi I. Joensuu
Supplementary Table 5 from Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16063568bc5e79cc65fa4fd45adf76df
https://doi.org/10.1158/0008-5472.22375274.v1
https://doi.org/10.1158/0008-5472.22375274.v1
Autor:
Päivi Peltomäki, Sakari Knuutila, Salla Ruosaari, Miina Ollikainen, Wael M. Abdel-Rahman, Emmi I. Joensuu
Supplementary Table 4 from Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1eea457da58f894d6896388197abac4
https://doi.org/10.1158/0008-5472.22375277
https://doi.org/10.1158/0008-5472.22375277
Autor:
Päivi Peltomäki, Sakari Knuutila, Salla Ruosaari, Miina Ollikainen, Wael M. Abdel-Rahman, Emmi I. Joensuu
Supplementary Table 6 from Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23702cd0cda74859739f4d77eeb1a28e
https://doi.org/10.1158/0008-5472.22375271
https://doi.org/10.1158/0008-5472.22375271
Autor:
Emmi I. Joensuu, Tommi Kauko, Heidi Loponen, Juha Ranti, Tiina M. Järvinen, Katariina Perkonoja
Publikováno v:
EJHaem. 3(1)
We conducted this retrospective study to characterize the change in chronic lymphocytic leukemia (CLL) treatment patterns between 2005 and 2019, to understand the treatment sequencing across the course of the disease, and to investigate how targeted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::843ba933afb8354c299194b80d2609a1
https://pubmed.ncbi.nlm.nih.gov/35846189
https://pubmed.ncbi.nlm.nih.gov/35846189
Autor:
Janne Raula, Ville Vartiainen, Nurcin Ugur, Luis M. Bimbo, Jenni Viinamäki, Marjukka Myllärniemi, Katri Koli, Esko I. Kauppinen, Eva Sutinen, Janne T. Backman, Emmi I. Joensuu
Publikováno v:
INTERNATIONAL JOURNAL OF PHARMACEUTICS. 544(1):121-128
The aim of this work was to study the antifibrotic effect of pulmonary administration of tilorone to lung fibrosis. L-leucine coated tilorone particles were prepared and their aerosolization properties were analyzed using two dry powder inhalers (Eas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e48d3cacd110f13f55ef4fc41c8d061
http://juuli.fi/Record/0330081218
http://juuli.fi/Record/0330081218
Autor:
Ville Vartiainen, Katri Koli, Veronika Rezov, Emmi I. Joensuu, Chang Li, Mikko Rönty, Miao Yin, Marjukka Myllärniemi
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Malignant mesothelioma is an aggressive cancer with poor prognosis. It is characterized by prominent extracellular matrix, mesenchymal tumor cell phenotypes and chemoresistance. In this study, the ability of pirfenidone to alter mesothelioma cell pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca596b91ebe653926f752aef7d68b9fc
https://doi.org/10.1038/s41598-018-28297-x
https://doi.org/10.1038/s41598-018-28297-x
Autor:
Wael M. Abdel-Rahman, Emmi I. Joensuu, Johanna E. Lotsari, Taina T. Nieminen, Päivi Peltomäki, Walter Hernán Pavicic
Publikováno v:
Genes, Chromosomes and Cancer. 54:776-787
Molecular mechanisms underlying coordinated hypermethylation of multiple CpG islands in cancer remain unclear and studies of methyltransferase enzymes have arrived at conflicting results. We focused on DNMT1 and DNMT3B, DNA methyltransferases respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23c8dc15cf39ea68e8f7b509fcde0c29
https://doi.org/10.1002/gcc.22289
https://doi.org/10.1002/gcc.22289
Autor:
Chang Li, Katri Koli, Emmi I. Joensuu, Veronika Rezov, Miao Yin, Mikko Rönty, Ville Vartiainen, Marjukka Myllärniemi
Publikováno v:
Cancer Research. 78:LB-014
The purpose of this study was to examine pirfenidone (PFD) as a potential new therapy for malignant pleural mesothelioma. PFD is an anti-fibrotic drug used to treat idiopathic pulmonary fibrosis (IPF). PFD reduces fibrous tissue formation e.g. by dow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1019a08e5b21fdfa3a12a0b80da917b
https://doi.org/10.1158/1538-7445.am2018-lb-014
https://doi.org/10.1158/1538-7445.am2018-lb-014
Autor:
Taina T. Nieminen, Päivi Peltomäki, M. Aarnio, Mecklin Jp, Annette Gylling, Kyösti Nuorva, Heikki Järvinen, Emmi I. Joensuu, Wael M. Abdel-Rahman, Matti Juhola
Publikováno v:
Carcinogenesis. 29:1351-1359
Hereditary non-polyposis colorectal carcinoma (Lynch syndrome) is among the most common hereditary cancers in man and a model of cancers arising through deficient DNA mismatch repair (MMR). Lynch syndrome patients are predisposed to different cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2732350a89b61ecf567803709a36b1d
https://doi.org/10.1093/carcin/bgn133
https://doi.org/10.1093/carcin/bgn133